Preclinical evaluation of 68Ga-labeled NM-01 (68Ga-NODAGA-NM-01) was conducted to validate its specific targeting ability in vivo in PD-L1-positive tumor-bearing mice. The gene discussed is CD274; the disease is neoplasm.